PA
AMED

Perceptive Advisors’s Amedisys AMED Stock Holding History

Perceptive Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,672
Closed -$422K – 108
2018
Q4 		$422K Buy
+3,672
New +$433K 0.02% 91
2016
Q2 		– Sell
-10,493
Closed -$507K – 175
2016
Q1 		$507K Buy
10,493
+5,845
+126% +$226K 0.04% 122
2015
Q4 		$183K Buy
+4,648
New +$186K 0.01% 133

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors's AMED Position: Q1 2019 in Review

Perceptive Advisors sold out of Amedisys (AMED) in Q1 2019, closing a stake of 3,672 shares — an estimated $422K sold.

Perceptive Advisors first reported a position in AMED in Q4 2015 and held it in 3 quarters. The position peaked at $507K in Q1 2016. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

  • Perceptive Advisors reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
  • Perceptive Advisors sold 3,672 Amedisys shares in Q1 2019, an estimated $422K.
  • Perceptive Advisors first reported a position in Amedisys in Q4 2015 and held it in 3 quarters.
  • Perceptive Advisors's Amedisys position peaked at $507K in Q1 2016.
  • 317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on Perceptive Advisors's 13F filing for Q1 2019, filed 15 May 2019.